Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences

Starting soon · Not applicable

Conditions studied: Cancer

In brief

This study of current or former cancer patients will evaluate the effect of learning about uncertainties with the benefits of a new cancer drug on their hypothetical decisions to take the drug and their perceptions of the drug's effectiveness.

Key facts

Study ID

NCT07694310

Run by

London School of Economics and Political Science

People needed

3000

Starts

2026-07-14

Expected to finish

2026-10-01

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• US adults with a current or former cancer diagnosis (excluding nonmelanoma skin cancer),
• 18 years of age and older
• Fluent in English
• Residing in the United States.

You may not qualify if…

• Adults who do not have a former cancer diagnosis or who were diagnosed with nonmelanoma skin cancer
• Adults who complete the survey in under 150 seconds, and who do not meet the inclusion criteria.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.